SC 13G Filing

Company

Arbutus Biopharma Corp

Filed

February 8, 2011

Accession Number

0000934729-11-000017

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →